Further more ATH has a history of never meeting targets and has never surprised the market with positive news. The last 24 months has just been rehashed stories about how save PBT434 has been.
Phase 2 trial was meant to have started in the second half of 2021, then extended to Q1 of this year. Now they expect to start in Q2 and as other have highlighted in this forum, not will start.
A very frustrating stock to hold from an over loyal long term holder.
Ann: UK Regulatory Authorisation to Proceed with Phase 2 Trial, page-8
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.001(33.3%) |
Mkt cap ! $15.96M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.4¢ | 0.4¢ | $45 | 12.93K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 37 | 22140821 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 130756600 | 30 |
View Market Depth
| Last trade - 16.10pm 09/10/2024 (20 minute delay) ? |
| ATH (ASX) Chart |